The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...

The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for children aged 5 years of older with active lupus nephritis (LN) who are receiving standard therapy.

Detalimogene voraplasmid gains FDA RMAT designation, showcasing a 71% response rate in treating high-risk, BCG-unresponsive ...

Benlysta is supplied as a single-dose prefilled autoinjector or prefilled syringe containing 200mg/mL of belimumab for SC use. The prefilled syringe has not been studied in pediatric patients aged ...

Mr. Jon E. RiceActing DirectorOffice of National Drug Control PolicyExecutive Office of the President Washington, D.C. 20503 RE: 2026 National Drug Control Strategy Dear Mr. Rice: The R Street ...

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

A team of doctors at Michigan Medicine have successfully treated a child in severe septic shock and multiorgan failure with ...

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety of nemolizumab in treating patients ...

MIAMI, FL / ACCESS Newswire / June 25, 2025 / iTolerance, Inc. (“iTolerance” or the “Company”), an early-stage privately-held ...

The first six minutes of the flight to Southern California’s Ontario International Airport were routine. The Boeing 737 Max 9 ...

The Association of Community Pharmacists of Nigeria, ACPN, has said that the current model, which grants physicians exclusive ...